-
A brain signature of prodromal Lewy body dementia
-
A C12orf65 mutation-related autosomal recessive hereditary spastic paraplegia is associated with autophagy induction
-
A case of cervical dystonia resulting from Vim-DBS surgery that was then responsive to stimulation: quantitative analysis of therapeutic effect on both fixed dystonic posture and dystonic tremor
-
A Case of Disabling Orofacial Dyskinesias Caused by Lupus Anticoagulant
-
A case of generalized early-onset dystonia with a novel low-penetrant THAP1 missense variant
-
A Case of Hemiballism Associated with Temporal Lobe Infarction
-
A Case of Improved Psychotic Depression and Motor Symptoms in Parkinson’s Disease following Electroconvulsive Therapy (ECT)
-
A Case of Lance Adams Syndrome with See-Saw Nystagmus
-
A case report of myoclonus-dystonia with isolated myoclonus phenotype and novel mutation successfully treated with deep brain stimulation
-
A Case Report of Spinocerebellar ataxia 13 with Parkinsonism
-
A Case Series Highlighting Non-Traditional Movement Disorder Candidates for Deep Brain Stimulation Therapy Who Benefited Positively
-
A day in the life of Parkinson’s: Using passive monitoring to characterize the disease at home
-
A Discrete-Choice Experiment Evaluating Preferences for On-Demand Treatments for Patients with Parkinson’s Disease and “OFF” Episodes
-
A Fluctuating Qualitative Dermatoglyphic Trait, Dankmeijer’s and Furuhata’s Index as a Risk Marker in Diabetic Parkinson’s Patients of Guyana: A Case-Control Study
-
A Korean first case of Boucher-Neuhäuser syndrome with two novel mutations of PNPLA6 gene
-
A large-scale full GBA1 gene screening in Parkinson’s disease in the Netherlands: 18 novel and 1 ‘Dutch’ variant
-
A Long-Term Safety, Tolerability, and Efficacy Study of Apomorphine Sublingual Film for On-Demand Treatment of “OFF” Episodes in De Novo vs Rollover Patients With Parkinson’s Disease: Interim Results
-
A Long-Term Safety, Tolerability, and Efficacy Study of Apomorphine Sublingual Film for On-Demand Treatment of “OFF” Episodes in Patients With Parkinson’s Disease: Interim Results
-
A longitudinal PET study to assess the state of microglia activation in a Phase 2 study of Laquinimod as a treatment for Huntington’s disease (LEGATO-HD)
-
A longitudinal study on alpha-synuclein in plasma neuronal exosomes as a biomarker for Parkinson’s disease development and progression
-
A monocentric experience of Apomorphine pump follow-up on PD patients: The Optipump Cohort
-
A New Complex dystonic presentation of a rare gene – CACNA1B and its response to Levodopa
-
A New Web-Based Tapping Test for Measuring Distal Bradykinesia in Parkinson’s Disease
-
A Novel CACNA1A Nonsense Variant [c.6481C>G; (p.Arg2161Gly)] Causing Spino Cerebellar Ataxia Type 6 (SCA6)
-
A Novel Case of Persistent Segmental Spinal Myoclonus Due to Spinal Astrocytoma Temporarily Relieved by Diversion of Cerebrovascular Fluid
-
A novel easily performed objective test of fine motor skill in handwriting and drawing to support diagnosing Parkinson’s disease
-
A novel likely pathogenic SNCA variant associated with Parkinson’s disease
-
A novel peptide reduces α-synuclein levels and neurodegeneration in cell, invertebrate, and mammalian models of Parkinson’s disease
-
A novel phasic and restricted basal ganglia thalamocortical subcircuitry model
-
A novel POLG2 variant leads to disrupted mitochondrial integrity in a family with cerebellar ataxia and progressive ophthalmoplegia
-
A Novel Variant of TUBB4A Dystonia (DYT4): A Case Report
-
A Parkinson’s disease (PD) case with underlying cerebral small vessel disease (CSVD)
-
A Parkinson’s disease dog providing therapeutic intervention in Parkinson’s disease
-
A Patient with Gait Disturbance Caused by Parkinson’s Disease: A Case Report
-
A pilot study on the efficacy, tolerability and safety of safinamide in elderly Parkinson’s disease patients
-
A pilot study on the shift from rasagiline to safinamide in fluctuating Parkinson’s disease patients
-
A pooled analysis of four pivotal, randomized controlled trials of istradefylline, an adenosine A2A receptor antagonist: Efficacy as adjunct to levodopa in Parkinson’s disease (PD)
-
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of AKST4290 in Subjects with Parkinson’s Disease on Stable Dopaminergic Treatment (TEAL Study)
-
A randomized, sham-controlled, crossover trial on Cerebello-Spinal Transcranial pulsed current stimulation (tPCS) in Ataxia
-
A Rare Disease with Atypical Clinical And Imaging Findings: Anti Lgi-1 Encephalitis
-
A reliable measure of rigidity with a novel robotic device
-
A retrospective analysis of multicenter brain signal data recorded in Parkinson’s subjects implanted with deep brain stimulation leads
-
A sensor-based analysis of freezing of turning in bed: A new manifestation of nocturnal hypokinesia
-
A study of gut microbiota dynamics in Parkinsonian mice
-
A Systematic Review of the Psychometric Properties of Psychosis Rating Scales in Neurodegenerative Conditions
-
A tailored and multifactorial fall prevention program for people with Parkinson’s disease: a feasibility study
-
A translational approach to determine target concentrations of MIN-102 (leriglitazone) to support a Phase II study in Friedreich’s ataxia
-
A video self-modelling virtual reality intervention for freezing of gait in Parkinson’s disease: Preliminary findings from a pilot trial
-
A Virtual Speech Therapist for Parkinson’s Disease
-
A Young Patient with Paroxysmal Choreoathetosis
-
AADC gene therapy administered via a posterior approach: 18-month results from the PD-1102 trial in advanced Parkinson’s disease
-
Aberrant resting-state functional connectivity in cognitively unimpaired patients with Parkinson´s disease and freezing of gait
-
Abnormal Cerebral Glucose Metabolism and Dopaminergic Dysfunction in Patients with Parkinson’s Disease with Bilateral Onset
-
Abnormal network interconnections dynamics correlate with levodopa-induced dyskinesia in Parkinson’s disease
-
Abnormal pattern of brain glucose metabolism in multiple system atrophy
-
Abrogation of neuroinflammation and behavioural deficit by Chlorogenic acid and Tinosporia cordiofolia in MPTP-Induced Parkinsonian mice model via suppressing NF-κB pathway
-
Accounting for unmeasured confounders in treatment response: a comparison of levodopa versus non-levodopa dopaminergic drugs
-
Aceruloplasminemia Presenting as Huntington’s Disease –Look –Alike with Unique MRI Features
-
Activated microglia contribute to MPTP-induced impairment of cardiovascular function
-
Acute Medically Refractory Hemichorea-Hemiballismus Treated by Unilateral Pallidotomy: A Case Report
-
ADAM10 polymorphisms are not associated with susceptibility to Parkinson’s disease and Parkinson’s disease with cognitive impairment in a Chinese cohort
-
Adaptive DBS Algorithm for Personalized Therapy in Parkinson’s Disease: ADAPT-PD Trial: A Prospective Single-Blind, Randomized Crossover, Multi-Center Trial of Deep Brain Stimulation Adaptive Algorithms in Subjects with Parkinson’s Disease
-
Adaptive vs Conventional deep brain stimulation for Parkinson’s disease: a eight-hours study
-
Adrenoleukodystrophy Spastic Gait: Treatment with Fampridine
-
Adult onset of Dandy-Walker Syndrome
-
Advance Care Planning in Complex Stage Parkinson’s Disease
-
Advance Care Planning in Parkinson’s Disease – Are we getting it right?
-
Age and gender differences in cardiovascular autonomic failure in transgenic PLP-syn mouse model of multiple system atrophy
-
Age at onset and Parkinson’s disease progression
-
Age-dependent expression of α-synuclein and its modification in non-neurodegenerative intestinal tract
-
Agreement Between Neurologists on UPDRS Scoring and Symptom Laterality
-
Alexithymia is associated with worse quality of life and caregiver burden in people with Parkinson’s disease
-
Alexithymia, Depression, and Cognition in Patients with Parkinson’s disease
-
All-cause mortality in pimavanserin and atypical antipsychotic users with Parkinson’s disease in Medicare
-
Allied health interventions for freezing of gait in Parkinson’s disease: a protocol for a systematic review and meta-analyses
-
Allogeneic bone marrow-derived mesenchymal stem cells safety and tolerability in idiopathic Parkinson’s disease
-
Alpha synuclein BAC transgenic mice as a preclinical model for disease-modifying therapies in Parkinson’s disease
-
Alpha-synuclein and Amyloid beta peptide 1-42 in Parkinson’s disease and parkinsonian plus syndrome cohorts
-
Alpha-synuclein DNA methylation in CD45+ blood cells in Parkinson’s disease
-
Alpha-synuclein preformed fibril (PFF)-triggered synucleinopathy recapitulates neurochemical features of human PD: A PET study in rats
-
Alterations in functional networks contribute to depression in Parkinson’s disease: A resting-state functional magnetic resonance imaging study
-
Altered interhemispheric synchrony in Parkinson’s disease patients with levodopa-induced dyskinesias
-
Altered metabolic and functional resting state activity in cognitively unimpaired and impaired Parkinson’s disease patients
-
Altered perceptual hand maps in focal hand dystonia
-
Altered Spontaneous Brain Activity in Essential Tremor with and without Resting Tremor: A Resting-state fMRI Study
-
Amantadine Therapy for Ataxia Management in Patients with Spinocerebellar Ataxia Type 7
-
Amantadine-induced negative myoclonus in a patient with Parkinson’s disease: A case report
-
Ambulatory Capacity Measure derived from the Movement Disorders Society Unified Parkinson’s Disease Rating Scale (MDS-UPDRS)
-
Ambulosono: A Novel Sensor-based System for Quantitative Evaluation Freezing of Gait in Parkinson’s disease
-
Among Parkinson’s disease patients with both OFF and dyskinesia, ADS-5102 (amantadine) extended-release reduces disruptive motor episodes and improves function: Analysis of phase 3 trials
-
Amplitude training in Parkinson’s disease: Improved dressing independence
-
Ampreloxetine (TD-9855), a long-acting, norepinephrine reuptake inhibitor (NRI) for the treatment of neurogenic orthostatic hypotension (nOH) in subjects with synucleinopathies: Phase 3 clinical program
-
An aberrant embouchure dystonia network predicts objective and functional measures of severity
-
An agent-based model replicates the pathogenic spread of alpha-synuclein in mice
-
An Analysis of Health Care Utilization in Functional Movement Disorders: Does Diagnosis Make a Difference?
-
An Analysis of Parkinson’s Disease Medication Treatment Patterns among Medicaid Patients
-
An Apparent Cluster of Parkinson’s Disease (PD) in a Golf Community
-
An introduction to the Global Parkinson’s Genetics Program (GP2)
-
An investigation of the relationships between measures of pain, physical activity levels, sleep quality and mood in people with Parkinson’s disease
-
An objective comparison of forward and backward postural instability in early Parkinson’s disease
-
An Objective Tool to Guide Target Selection for DBS in PD (GPi vs STN)- integration into Thomas Jefferson’s multidisciplinary Movement Disorders Center, an Update
-
An Observational Study for the Application of Wearable, Multi-Sensor Technology to Characterize Motor Function of Parkinson’s Disease Patients in Japan (SWJ-001): An Innovative Protocol
-
An Observational Study for the Application of Wearable, Multi-Sensor Technology to Characterize Motor Function of Parkinson’s disease Patients in Japan (SWJ-001): Device Adherence
-
An Open-Label, Phase 1b Study of the Neuroactive Steroid GABAA Receptor Positive Allosteric Modulator SAGE-324 in Essential Tremor
-
An overview of vestibular function in Parkinson’s disease
-
An uncommon clinical phenotype associated with ANO10 mutation
-
An unusual phenotype of spinocerebellar ataxia type 12
-
Analysing an extension type of Parkinson’s disease
-
Analysis of cases with Huntington’s disease phenotype and negative genetic test for huntingtin mutations in the Center for Movement Disorders (CETRAM) in Chile
-
Analysis of pupillometer results according to motor symptoms severity in Parkinson’s disease patients
-
Anatomy-guided injections of Botulinum neurotoxin in neck muscles: how accurate is needle placement?
-
Andrograholide protect microglial activation via inhibiting mitochondrial ROS generation and NLRP3 inflammasome activation in in-vitro and in-vivo model of Parkinson’s disease
-
Anti-parkinson effect of natural L-DOPA containing drug Mucuna pruriens against the rotenone induced rat model of Parkinson’s disease
-
Anticholinergic Burden in Parkinson’s Disease Patients in India – A Hospital Based Study
-
Anticholinergic Use in Parkinson’s Disease: Practice Patterns in Patients with Cognitive Impairment
-
Anxiety disorders are associated with verbal memory impairment in Parkinson’s disease
-
Anxiety in Parkinson’s disease is associated with changes in the brain fear circuit
-
Apathy as a non-motor symptom(NMS) in patients with Parkinson’s disease(PwPD) and patients with Huntington’s disease(PwHD) in Tomsk, Russia
-
APOE, TREM2 and LINGO1 genes: A possible implication in cognition in essential tremor in a Tunisian population
-
Apolipoprotein E ε4 and risk of freezing of gait in early Parkinson’s disease
-
Apomorphine as a Diagnostic tool to Identify Levodopa Responsive Atypical Parkinsonism
-
Apomorphine improves pulmonary function in parkinsonian patients
-
Apomorphine subcutaneous infusion reduces dopaminergic dosage whilst maintaining motor benefits in Parkinson’s disease: A prospective analysis of Thai Apomorphine Registry
-
Apomorphine Sublingual Film for On-Demand Treatment of “OFF” Episodes in Patients With Parkinson’s Disease: Effect on MDS-UPDRS Part III Subdomains
-
Apomorphine Sublingual Film for On-Demand Treatment of “OFF” Episodes in Patients With Parkinson’s Disease: Impact of Concomitant Antiemetics and Dopamine Agonists on Nausea and Vomiting
-
Apomorphine Sublingual Film for On-Demand Treatment of “OFF” Episodes in Patients With Parkinson’s Disease: Impact on Dyskinesia
-
Apomorphine Sublingual Film for On-Demand Treatment of “OFF” Episodes in Patients With Parkinson’s Disease: Impact on Impulse Control Disorders
-
Application of a Simple Parkinson’s Disease Risk Score in a Longitudinal Population Based Cohort
-
Application of Deep Neuronal Networks for the extraction of spectral characteristics in patients with Parkinson’s disease
-
Application of PKG System for Objective Measurement and Early Identification in Parkinson’s Disease
-
Application of substantia nigra feature extraction in the progression of Parkinson’s disease based on magnitude image of susceptibility weighted imaging
-
Approach to the patients with the hallucinations, in the Parkinson’s disease in the low-income country and environment of restricted medications and stigmas
-
Aquatic Physiotherapy increases ventilatory parameters in Parkinson’s disease
-
Are effects of Rock Steady Boxing and PD SAFExTM on the motor symptoms of Parkinson’s disease maintained long-term? – A single-blinded randomized controlled trial
-
Are functional movement disorder phenotypes or age at onset correlated with perfectionist personality trait or history of abuse?
-
Are New York City rail tracks harbingers for Parkinson’s disease?
-
Are oromotor deficits a late stage signs in Parkinson’s disease?
-
Arm Swing Differences in Patients with PD and ET during Walking
-
Asleep versus Awake DBS: Real World Evidence from the Product Surveillance Registry
-
Assessing the Safety and Tolerability of ABBV-951 (Foscarbidopa/Foslevodopa) in Advanced Parkinson’s Disease Patients During a 52-Week Phase 3 Study: Study Design and Updated Patient Baseline Characteristics
-
Assessing the screening performance of three abbreviated smell tests in Parkinson’s disease
-
Assessment of Real World Effectiveness: A Deep Brain Stimulation Retrospective Outcomes Study
-
Association between actively and passively monitored gait in early Parkinson’s disease
-
Association between actively and passively monitored hand gestures in early Parkinson’s disease
-
Association between BDNF Val66Met polymorphism and mild behavioral impairment in patients with Parkinson’s patients
-
Association Between Diet & Parkinson’s Disease Progression
-
Association between essential tremor, constipation, and the risk of developing Parkinson’s disease
-
Association Between Fatigue, Depression and Sleep Disorders in People with Parkinson’s Disease
-
Association between Glutamic Acid Decarboxylase Antibodies (Anti-GADs) and Parkinsonism: Case Report
-
Association between impulse control disorders and depression in drug-naïve Parkinson’s disease
-
Association between motor symptoms and striatal VMAT2 binding in PD: a PET study
-
Association between non-motor symptoms and severity of axial symptoms in patients with Parkinson’s disease
-
Association between prediagnostic symptoms and patterns of treatment initiation in people with Parkinson´s disease in the United Kingdom
-
Association between SNCA and clinical phenotypes of Parkinson’s disease in southern Chinese
-
Association between the number of CAG repetitions and cognitive performance in Huntington’s disease in patients of the National Institute of Neurology and Neurosurgery “MVS”
-
Association Between Ventricle/Brain Volumes and Mobility Metrics in Parkinson’s Disease
-
Association between ZNF184 and symptoms of Parkinson’s disease in southern Chinese
-
Association of environmental exposure to herbicides, fungicides, and insecticides used in agriculture with incidence of Parkinson’s disease in the French general population
-
Association of gait domains with cognitive and neuropsychiatric domains in patients with Parkinson’s disease: A Brazilian exploratory study
-
Association of Interleukin (IL)-2 and IL2RA gene polymorphisms with Parkinson’s disease in Taiwan
-
Association of TTPA mutation and peripheral nerve involvement in Gait disturbances in Ataxia With Vitamin E Deficiency (AVED)
-
Associations between balance confidence, gait, postural stability, and muscle strength in people with Parkinson’s disease
-
Associations between subjective and objective cognitive decline in Parkinson’s disease
-
Asymmetrical cochlear dysfunction as a lateralized non-motor feature in Parkinson’s disease
-
Asymmetrical resting legs tremor induced by levosulpiride
-
Ataxia and action myoclonus with biallelic mutations in ATP13A2 gene
-
Attitudes of Care Partners Toward Medications for Parkinson’s Disease Psychosis
-
Attitudes towards disease in patients with essential tremor
-
Atypical alternating hemiplegia of childhood in Korea: A case report
-
Atypical parkinsonism due to a mutation in the SLC9A6 gene
-
Atypical Psychogenic Nonepileptic Seizure (PNES) preceding Multiple System Atrophy (MSA)
-
Automated Capture of Deep Brain Stimulation Settings & Clinical Outcomes
-
Automated classification of neurodegenerative parkinsonian syndromes using multimodal magnetic resonance imaging in a clinical setting
-
Automated pattern based classification in neuropathology proven parkinsonism
-
Automatic classification of abnormal movement in Huntington’s disease using wearable sensors and machine learning
-
Automatic Detection of Nigrosome Degeneration in Susceptibility-Weighted MRI for Computer-Aided Diagnosis of Parkinson’s Disease Using Machine Learning
-
Autonomic symptoms as biomarkers in REM Sleep Behavior Disorder and Parkinson’s disease
-
Autosomal recessive spastic ataxia of Charlevoix-Saguenay: A Mexican case report
-
Auxilin knockout mice: a model for Parkinsonism with dopamine dysregulation and synucleinopathy
-
Axial myoclonus and cerebellar ataxia in a patient with mutation in ADCK3
MDS Virtual Congress 2020
September 12-16, 2020. Virtual Congress. www.mdscongress.org